Murine motor and behavior functional evaluations for acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intoxication

Journal of Neuroimmune Pharmacology

Volumn 7, Issue 1, 2012, Pages 279-288

  Hutter Saunders, Jessica A L ^a   Gendelman, Howard E ^a   Mosley, R Lee ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Behavior; Grooming; Mice; MPTP; Open field; Parkinson's disease; Rotarod

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; INTOXICATION; MALE; MOTOR PERFORMANCE; MOUSE; MUSCLE EXERCISE; MUSCLE STRENGTH; NEUROMUSCULAR FUNCTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ANIMALS; BEHAVIOR, ANIMAL; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; MPTP POISONING;

EID: 84860738441     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-011-9269-4     Document Type: Article

References (39)

1. Aldridge JW, Berridge KC (1998) Coding of serial order by neostriatal neurons: a "natural action" approach to movement sequence. J Neurosci 18:2777-2787
2. Aldridge JW, Berridge KC, Rosen AR (2004) Basal ganglia neural mechanisms of natural movement sequences. Can J Physiol Pharmacol 82:732-739 (Pubitemid 40065118)
3. Banerjee R, Mosley RL, Reynolds AD, Dhar A, Jackson-Lewis V, Gordon PH, Przedborski S, Gendelman HE (2008) Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice. PLoS ONE 3:e2740
4. Benner EJ, Mosley RL, Destache CJ, Lewis TB, Jackson-Lewis V, Gorantla S, Nemachek C, Green SR, Przedborski S, Gendelman HE (2004) Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease. Proc Natl Acad Sci USA 101:9435-9440 (Pubitemid 38812892)
5. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415-455
6. Berridge KC (1989) Progressive degradation of serial grooming chains by descending decerebration. Behav Brain Res 33:241-253 (Pubitemid 19160681)
7. Berridge KC, Fentress JC, Parr H (1987) Natural syntax rules control action sequence of rats. Behav Brain Res 23:59-68 (Pubitemid 17234532)
8. Berridge KC, Aldridge JW, Houchard KR, Zhuang X (2005) Sequential super-stereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: a model of obsessive compulsive disorder and Tourette's. BMC Biol 3:4
9. Crawley JN (2007) What's wrong with my mouse?: Behavioral phenotyping of transgenic and knockout mice. Wiley, Hoboken
10. Crawley JN, Paylor R (1997) A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Horm Behav 31:197-211 (Pubitemid 27305718)
11. Cromwell HC, Berridge KC (1996) Implementation of action sequences by a neostriatal site: a lesion mapping study of grooming syntax. J Neurosci 16:3444-3458 (Pubitemid 26142374)
12. Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39:889-909 (Pubitemid 37130207)
13. Fredriksson A, Archer T (1994) MPTP-induced behavioural and biochemical deficits: a parametric analysis. J Neural Transm Park Dis Dement Sect 7:123-132
14. Hall (1934) Emotional behavior in the rat. 1. Defecation and urination as measures of individual differences in emotionality. J Comp Physiol 18:385-403
15. Heikkila RE, Hess A, Duvoisin RC (1984) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science 224:1451-1453 (Pubitemid 14123348)
16. Hirst SJ, Ferger B (2008) Systemic proteasomal inhibitor exposure enhances dopamine turnover and decreases dopamine levels but does not affect MPTP-induced striatal dopamine depletion in mice. Synapse 62:85-90
17. Jackson-Lewis V, Przedborski S (2007) Protocol for the MPTP mouse model of Parkinson's disease. Nat Protoc 2:141-151 (Pubitemid 47044700)
18. Jackson-Lewis V, Jakowec M, Burke RE, Przedborski S (1995) Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 4:257-269
19. Jones BJ, Roberts DJ (1968) The quantiative measurement of motor inco-ordination in naive mice using an accelerating rotarod. J Pharm Pharmacol 20:302-304
20. Jurkowski AJS, Stacy M (2005) Classification and clinical features of movement disorders. In: LeDoux M (ed) Animal Models of Movement Disorders. Elsevier Academic Press, Burlington, pp 1-12
21. Keshet GI, Tolwani RJ, Trejo A, Kraft P, Doyonnas R, Clayberger C, Weimann JM, Blau HM (2007) Increased host neuronal survival and motor function in BMT Parkinsonian mice: involvement of immunosuppression. J Comp Neurol 504:690-701 (Pubitemid 350246582)
22. LeDoux MS (2005) Animal models of movement disorders. Elsevier Academic Press, Burlington
23. Luchtman DW, Shao D, Song C (2009) Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease. Physiol Behav 98:130-138
24. Meredith GE, Kang UJ (2006) Behavioral models of Parkinson's disease in rodents: a new look at an old problem. Mov Disord 21:1595-1606 (Pubitemid 44742185)
25. Meredith GE, Totterdell S, Potashkin JA, Surmeier DJ (2008) Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol. Parkinsonism Relat Disord 14(Suppl 2):S112-115
26. Petzinger GM, Walsh JP, Akopian G, Hogg E, Abernathy A, Arevalo P, Turnquist P, Vuckovic M, Fisher BE, Togasaki DM, Jakowec MW (2007) Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine- lesioned mouse model of basal ganglia injury. J Neurosci 27:5291-5300 (Pubitemid 46790176)
27. Przedborski S, Jackson-Lewis V, Naini AB, Jakowec M, Petzinger G, Miller R, Akram M (2001) The parkinsonian toxin 1-methyl-4- phenyl-1,2,3,6- tetrahydropyridine (MPTP): a technical review of its utility and safety. J Neurochem 76:1265-1274 (Pubitemid 32198231)
28. Rousselet E, Joubert C, Callebert J, Parain K, Tremblay L, Orieux G, Launay JM, Cohen-Salmon C, Hirsch EC (2003) Behavioral changes are not directly related to striatal monoamine levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice. Neurobiol Dis 14:218-228 (Pubitemid 37311286)
29. Rozas G, Guerra MJ, Labandeira-Garcia JL (1997) An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism. Brain Res Brain Res Protoc 2:75-84 (Pubitemid 28277496)
30. Rozas G, Lopez-Martin E, Guerra MJ, Labandeira-Garcia JL (1998) The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism. J Neurosci Meth 83:165-175 (Pubitemid 28442608)
31. Schwarting RK, Sedelis M, Hofele K, Auburger GW, Huston JP (1999) Strain-dependent recovery of open-field behavior and striatal dopamine deficiency in the mouse MPTP model of Parkinson's disease. Neurotox Res 1:41-56
32. Sedelis M, Hofele K, Auburger GW, Morgan S, Huston JP, Schwarting RK (2000) MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences. Behav Genet 30:171-182
33. Seniuk NA, Tatton WG, Greenwood CE (1990) Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP. Brain Res 527:7-20 (Pubitemid 20290579)
34. Sonsalla PK, Heikkila RE (1986) The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice. Eur J Pharmacol 129:339-345 (Pubitemid 16008029)
35. Sundstrom E, Fredriksson A, Archer T (1990) Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease. Brain Res 528:181-188 (Pubitemid 20318194)
36. Taylor JL, Rajbhandari AK, Berridge KC, Aldridge JW (2010) Dopamine receptor modulation of repetitive grooming actions in the rat: potential relevance for Tourette syndrome. Brain Res 1322:92-101
37. Tillerson JL, Miller GW (2003) Grid performance test to measure behavioral impairment in the MPTP-treated-mouse model of parkinsonism. J Neurosci Meth 123:189-200 (Pubitemid 36279413)
38. Tillerson JL, Caudle WM, Reveron ME, Miller GW (2002) Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine. Exp Neurol 178:80-90 (Pubitemid 35425611)
39. Weydt P, Hong SY, Kliot M, Moller T (2003) Assessing disease onset and progression in the SOD1 mouse model of ALS. NeuroReport 14:1051-1054 (Pubitemid 36829789)